{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:27:11Z","timestamp":1792207631012,"version":"4.4.0"},"reference-count":57,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,24]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but serious complication of the ChAdOx1 nCOV-19 vaccine. In Australia, the diagnosis of VITT required the detection of antibodies against platelet factor 4 (PF4) in plasma using a PF4\/polyanion enzyme-linked immunosorbent assay (ELISA). Half of the patients who fulfilled the clinical criteria for VITT tested positive when using this ELISA and another third tested positive when using platelet activation assays, highlighting limitations in the assays used for VITT. Using a microfluidic device coated with endothelial cells, the Endo-chip, we measured the effects of serum and immunoglobulin G (IgG) from patients with clinical VITT on endothelial thromboinflammation. Our cohort comprised 40 patients (21 ELISA-positive and 19 ELISA-negative patients as measured by PF4\/polyanion ELISA), 12 vaccinated patients with venous thromboembolism without VITT, and 17 individuals who received the ChAdOx1 vaccine without adverse events (vax controls). Treatment with VITT serum, plasma, or IgG increased endothelial tissue factor (TF) expression and activity. Perfusion of blood from healthy donors labelled with fluorescent antibodies against platelets, neutrophils, and fibrin through Endo-chips treated with VITT serum or IgG induced a twofold to threefold increase in platelet, neutrophil, and fibrin deposition. Thromboinflammation was enhanced with addition of PF4 and reduced with an inhibitory antibody against TF. We conclude that endothelial activation contributes to thromboinflammation in patients with clinical features of VITT. The Endo-chip offers a platform for the study of endothelial responses in immune thrombosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024014165","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T22:25:37Z","timestamp":1741991137000},"page":"2891-2906","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia"],"prefix":"10.1182","volume":"9","author":[{"given":"Alexander","family":"Dupuy","sequence":"first","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"2Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"},{"name":"3Heart Research Institute, Sydney, Australia"},{"name":"4Sydney Nano Institute (Sydney Nano), The University of Sydney, Sydney, Australia"},{"name":"5School of Biomedical Engineering, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-1356","authenticated-orcid":false,"given":"Xiaoming","family":"Liu","sequence":"additional","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"2Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"},{"name":"3Heart Research Institute, Sydney, Australia"},{"name":"4Sydney Nano Institute (Sydney Nano), The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Kong","sequence":"additional","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"2Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"},{"name":"3Heart Research Institute, Sydney, Australia"},{"name":"4Sydney Nano Institute (Sydney Nano), The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Qi","sequence":"additional","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"2Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1554-708X","authenticated-orcid":false,"given":"Jose","family":"Perdomo","sequence":"additional","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"2Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3753-8268","authenticated-orcid":false,"given":"Jemma","family":"Fenwick","sequence":"additional","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"2Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tieng","sequence":"additional","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"6Centenary Institute, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bede","family":"Johnston","sequence":"additional","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"3Heart Research Institute, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyu Sara","family":"Shi","sequence":"additional","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"2Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"},{"name":"7School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-2267","authenticated-orcid":false,"given":"Mark","family":"Larance","sequence":"additional","affiliation":[{"name":"7School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Zhang","sequence":"additional","affiliation":[{"name":"4Sydney Nano Institute (Sydney Nano), The University of Sydney, Sydney, Australia"},{"name":"5School of Biomedical Engineering, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-0864","authenticated-orcid":false,"given":"Lining Arnold","family":"Ju","sequence":"additional","affiliation":[{"name":"3Heart Research Institute, Sydney, Australia"},{"name":"4Sydney Nano Institute (Sydney Nano), The University of Sydney, Sydney, Australia"},{"name":"5School of Biomedical Engineering, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coleman","sequence":"additional","affiliation":[{"name":"6Centenary Institute, Sydney, Australia"},{"name":"7School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gamble","sequence":"additional","affiliation":[{"name":"6Centenary Institute, Sydney, Australia"},{"name":"7School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-9688","authenticated-orcid":false,"given":"Elizabeth E.","family":"Gardiner","sequence":"additional","affiliation":[{"name":"8Division of Genome Science and Cancer, The John Curtin School of Medical Research, Australian National University Canberra, Canberra, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-3613","authenticated-orcid":false,"given":"Mortimer","family":"Poncz","sequence":"additional","affiliation":[{"name":"9Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA"},{"name":"10Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-959X","authenticated-orcid":false,"given":"Huyen","family":"Tran","sequence":"additional","affiliation":[{"name":"11Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia"},{"name":"12Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-7470","authenticated-orcid":false,"given":"Vivien","family":"Chen","sequence":"additional","affiliation":[{"name":"13Department of Haematology, Concord Repatriation General Hospital, Sydney, Australia"},{"name":"14ANZAC Research Institute, The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4584-2044","authenticated-orcid":false,"given":"Freda H.","family":"Passam","sequence":"additional","affiliation":[{"name":"1Haematology Research Group, Charles Perkins Centre, The University of Sydney, Sydney, Australia"},{"name":"2Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"},{"name":"3Heart Research Institute, Sydney, Australia"},{"name":"4Sydney Nano Institute (Sydney Nano), The University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"22","key":"2025062410214411200_bib1","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"2025062410214411200_bib2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"2025062410214411200_bib3","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"2025062410214411200_bib4","first-page":"2010","article-title":"Cerebral venous sinus thrombosis and thrombocytopenia due to heparin-independent anti-PF4 antibodies after adenovirus infection","volume":"109","author":"Uzun","year":"2024","journal-title":"Haematologica"},{"issue":"6","key":"2025062410214411200_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMc2307721","article-title":"Adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies","volume":"389","author":"Warkentin","year":"2023","journal-title":"N Engl J Med"},{"issue":"26","key":"2025062410214411200_bib6","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.2023022136","article-title":"Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure","volume":"142","author":"Sch\u00f6nborn","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2025062410214411200_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/hematology.2023000503","article-title":"Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond","volume":"2023","author":"Greinacher","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2025062410214411200_bib8","unstructured":"Thrombosis & Haemostasis Society of Australia and New Zealand\n          . Suspected vaccine induced immune thrombotic thrombocytopenia (VITT): THANZ advisory statement for haematologists. Updated 18 December 2021. Accessed 23 December 2024. https:\/\/www.thanz.org.au\/documents\/item\/591."},{"issue":"18","key":"2025062410214411200_bib9","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"2025062410214411200_bib10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.15341","article-title":"Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: communication from the ISTH SSC Subcommittee on Platelet Immunology","volume":"19","author":"Nazy","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2025062410214411200_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5694\/mja2.51229","article-title":"Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia","volume":"215","author":"Chen","year":"2021","journal-title":"Med J Aust"},{"issue":"12","key":"2025062410214411200_bib12","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1111\/jth.15881","article-title":"Assessment of immunological anti-platelet factor 4 antibodies for vaccine-induced thrombotic thrombocytopenia (VITT) in a large Australian cohort: a multicenter study comprising 1284 patients","volume":"20","author":"Favaloro","year":"2022","journal-title":"J Thromb Haemost"},{"key":"2025062410214411200_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-1-0716-3175-1_28","article-title":"Multiple electrode aggregometry (Multiplate): functional assay for vaccine-induced (immune) thrombotic thrombocytopenia (VITT)","volume":"2663","author":"Kong","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"11","key":"2025062410214411200_bib14","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/bloodadvances.2021006698","article-title":"A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia","volume":"6","author":"Lee","year":"2022","journal-title":"Blood Adv"},{"issue":"suppl 1","key":"2025062410214411200_bib15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1182\/blood-2021-151685","article-title":"Vaccine-induced thrombocytopenia and thrombosis (VITT) antibodies recognize neutrophil-activating peptide 2 (NAP2) as well as platelet factor 4 (PF4): mechanistic and clinical implications","volume":"138","author":"Rauova","year":"2021","journal-title":"Blood"},{"issue":"11","key":"2025062410214411200_bib16","doi-asserted-by":"crossref","first-page":"e151092","DOI":"10.1172\/JCI151092","article-title":"Is complement the culprit behind COVID-19 vaccine-related adverse reactions?","volume":"131","author":"Mastellos","year":"2021","journal-title":"J Clin Invest"},{"issue":"3","key":"2025062410214411200_bib17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jtha.2023.10.027","article-title":"Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation","volume":"22","author":"Keragala","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2025062410214411200_bib18","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.jtha.2023.09.007","article-title":"Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis","volume":"21","author":"Simpson","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"7873","key":"2025062410214411200_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"issue":"22","key":"2025062410214411200_bib20","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood"},{"key":"2025062410214411200_bib21","doi-asserted-by":"crossref","first-page":"102662","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection","volume":"121","author":"McGonagle","year":"2021","journal-title":"J Autoimmun"},{"issue":"8","key":"2025062410214411200_bib22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.ATV.0000229658.76797.30","article-title":"Flow effects on coagulation and thrombosis","volume":"26","author":"Hathcock","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"23","key":"2025062410214411200_bib23","first-page":"1","article-title":"Novel movable typing for personalized Vein-Chips in large scale: recapitulate patient-specific Virchow\u2019s triad and its contribution to cerebral venous sinus thrombosis","volume":"33","author":"Zhao","year":"2023","journal-title":"Adv Funct Mater"},{"issue":"3","key":"2025062410214411200_bib24","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI90958","article-title":"Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia","volume":"127","author":"Hayes","year":"2017","journal-title":"J Clin Invest"},{"issue":"12","key":"2025062410214411200_bib25","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1111\/jth.13516","article-title":"Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH","volume":"14","author":"Morel-Kopp","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2025062410214411200_bib26","first-page":"1","article-title":"Thrombo-inflammation model-on-a-chip by whole blood microfluidics on fixed human endothelium","volume":"11","author":"Dupuy","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"2025062410214411200_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3109\/09537104.2012.724736","article-title":"Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study","volume":"24","author":"Galea","year":"2013","journal-title":"Platelets"},{"issue":"5","key":"2025062410214411200_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0038-1646454","article-title":"An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma","volume":"66","author":"Ruf","year":"1991","journal-title":"Thromb Haemost"},{"issue":"11","key":"2025062410214411200_bib29","doi-asserted-by":"crossref","first-page":"e163808","DOI":"10.1172\/JCI163808","article-title":"TMEM16E regulates endothelial cell procoagulant activity and thrombosis","volume":"133","author":"Schmaier","year":"2023","journal-title":"J Clin Invest"},{"issue":"26","key":"2025062410214411200_bib30","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood.2021012064","article-title":"A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination","volume":"137","author":"Handtke","year":"2021","journal-title":"Blood"},{"issue":"6260","key":"2025062410214411200_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/343757a0","article-title":"Rapid neutrophil adhesion to activated endothelium mediated by GMP-140","volume":"343","author":"Geng","year":"1990","journal-title":"Nature"},{"issue":"22","key":"2025062410214411200_bib32","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1182\/bloodadvances.2024013883","article-title":"Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments","volume":"8","author":"Leung","year":"2024","journal-title":"Blood Adv"},{"issue":"20","key":"2025062410214411200_bib33","doi-asserted-by":"crossref","first-page":"e151527","DOI":"10.1172\/jci.insight.151527","article-title":"Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19","volume":"6","author":"Schmaier","year":"2021","journal-title":"JCI Insight"},{"issue":"5","key":"2025062410214411200_bib34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood.2021014712","article-title":"Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration","volume":"140","author":"Nicolai","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2025062410214411200_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-\u03b1 production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat Commun"},{"issue":"23","key":"2025062410214411200_bib36","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1182\/blood.2021013839","article-title":"The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia","volume":"139","author":"Singh","year":"2022","journal-title":"Blood"},{"issue":"1","key":"2025062410214411200_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"issue":"2","key":"2025062410214411200_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/intimm\/14.2.121","article-title":"Anti-platelet factor 4\/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells","volume":"14","author":"Blank","year":"2002","journal-title":"Int Immunol"},{"issue":"1","key":"2025062410214411200_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-32946-1","article-title":"NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia","volume":"13","author":"Leung","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"2025062410214411200_bib40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.ATV.15.5.612","article-title":"Transcriptional regulation of tissue factor expression in human endothelial cells","volume":"15","author":"Parry","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025062410214411200_bib41","unstructured":"The Human Protein Atlas\n          . . Accessed 1 December 2024. https:\/\/www.proteinatlas.org\/ENSG00000143226-FCGR2A\/tissue."},{"key":"2025062410214411200_bib42","unstructured":"Therapeutic Goods Administration (TGA)\n          . COVID-19 vaccines weekly safety report: 27 January 2022. Australian Government Department of Health; Updated 27 January 2022. Accessed 9 March 2023. https:\/\/www.tga.gov.au\/news\/covid-19-vaccine-safety-reports\/covid-19-vaccine-weekly-safety-report-27-01-2022."},{"issue":"3","key":"2025062410214411200_bib43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5694\/j.1326-5377.2008.tb01947.x","article-title":"The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia","volume":"189","author":"Ho","year":"2008","journal-title":"Med J Aust"},{"issue":"10","key":"2025062410214411200_bib44","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3324\/haematol.2021.280251","article-title":"The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies","volume":"107","author":"Vayne","year":"2022","journal-title":"Haematologica"},{"issue":"2","key":"2025062410214411200_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.seminhematol.2022.03.003","article-title":"Laboratory testing for VITT antibodies","volume":"59","author":"Warkentin","year":"2022","journal-title":"Semin Hematol"},{"issue":"8","key":"2025062410214411200_bib46","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/jth.15362","article-title":"Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination","volume":"19","author":"Platton","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2025062410214411200_bib47","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/vox.13633","article-title":"Laboratory approach for vaccine-induced thrombotic thrombocytopenia diagnosis in the Netherlands","volume":"119","author":"Meier","year":"2024","journal-title":"Vox Sang"},{"issue":"2","key":"2025062410214411200_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V88.2.410.bloodjournal882410","article-title":"Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia","volume":"88","author":"Amiral","year":"1996","journal-title":"Blood"},{"issue":"4","key":"2025062410214411200_bib49","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jtha.2023.12.008","article-title":"Damage-associated cellular markers in the clinical and pathogenic profile of vaccine-induced immune thrombotic thrombocytopenia","volume":"22","author":"Abrams","year":"2024","journal-title":"J Thromb Haemost"},{"key":"2025062410214411200_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.860689","article-title":"Ex vivo test for measuring complement attack on endothelial cells: from research to bedside","volume":"13","author":"Meuleman","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"2025062410214411200_bib51","doi-asserted-by":"crossref","first-page":"111930","DOI":"10.1016\/j.celrep.2022.111930","article-title":"Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors","volume":"42","author":"Gray","year":"2023","journal-title":"Cell Rep"},{"issue":"10","key":"2025062410214411200_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm13102794","article-title":"Serum plasminogen activator inhibitor-1, \u03b1 1-acid glycoprotein, C-reactive protein, and platelet factor 4 levels-promising molecules that can complete the \u201cpuzzle\u201d of the biochemical milieu in severe burns: preliminary results of a cohort prospective study","volume":"13","author":"Badoiu","year":"2024","journal-title":"J Clin Med"},{"issue":"15","key":"2025062410214411200_bib53","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood.2018881607","article-title":"Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation","volume":"135","author":"Johnston","year":"2020","journal-title":"Blood"},{"key":"2025062410214411200_bib54","first-page":"1","article-title":"New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"21","key":"2025062410214411200_bib55","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood.2020009487","article-title":"Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes","volume":"138","author":"Khandelwal","year":"2021","journal-title":"Blood"},{"issue":"5","key":"2025062410214411200_bib56","first-page":"966","article-title":"Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity","volume":"110","author":"Collier","year":"2013","journal-title":"Thromb Haemost"},{"issue":"7","key":"2025062410214411200_bib57","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/art.42094","article-title":"Endothelial cell-activating antibodies in Covid-19","volume":"74","author":"Shi","year":"2022","journal-title":"Arthritis Rheumatol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/12\/2891\/2378973\/blooda_adv-2024-014165-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/12\/2891\/2378973\/blooda_adv-2024-014165-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:45:03Z","timestamp":1750776303000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/12\/2891\/536042\/Endothelial-cell-activation-enhances"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,6,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024014165","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,24]]},"published":{"date-parts":[[2025,6,11]]}}}